225 related articles for article (PubMed ID: 20626709)
1. A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
Sun HY; Shields RK; Cacciarelli TV; Muder RR; Singh N
Transpl Infect Dis; 2010 Dec; 12(6):555-60. PubMed ID: 20626709
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
[TBL] [Abstract][Full Text] [Related]
3. Current therapies for pseudomonas aeruginosa.
Giamarellou H; Kanellakopoulou K
Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
[TBL] [Abstract][Full Text] [Related]
4. Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia.
Kim J; Kang CI; Baek JY; Cho SY; Kim SH; Ko KS; Chung DR; Peck KR; Song JH
Int J Antimicrob Agents; 2014 Apr; 43(4):391-3. PubMed ID: 24637223
[No Abstract] [Full Text] [Related]
5. Successful treatment of post-neurosurgical multidrug-resistant Pseudomonas aeruginosa meningo-encephalitis with combination therapy of colistin, rifampicin and doripenem.
Morelli P; Ferrario A; Tordato F; Piazza A; Casari E
J Antimicrob Chemother; 2014 Mar; 69(3):857-9. PubMed ID: 24169582
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa.
Gelfand MS; Cleveland KO; Mazumder SA
J Antimicrob Chemother; 2009 Jun; 63(6):1297-9. PubMed ID: 19369268
[No Abstract] [Full Text] [Related]
8. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
Johnson LE; D'Agata EM; Paterson DL; Clarke L; Qureshi ZA; Potoski BA; Peleg AY
Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
10. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
[TBL] [Abstract][Full Text] [Related]
11. Clinical and microbiological efficacy of colistin therapy in combination with rifampin and imipenem in multidrug-resistant Pseudomonas aeruginosa diabetic foot infection with osteomyelitis.
Tascini C; Menichetti F; Gemignani G; Palumbo F; Leonildi A; Tedeschi A; Piaggesi A
Int J Low Extrem Wounds; 2006 Sep; 5(3):213-6. PubMed ID: 16928678
[TBL] [Abstract][Full Text] [Related]
12. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Kwa AL; Loh C; Low JG; Kurup A; Tam VH
Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101
[TBL] [Abstract][Full Text] [Related]
13. Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis.
Berlana D; Llop JM; Manresa F; Jódar R
Pharmacotherapy; 2011 Feb; 31(2):146-57. PubMed ID: 21275493
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients.
Shi SH; Kong HS; Xu J; Zhang WJ; Jia CK; Wang WL; Shen Y; Zhang M; Zheng SS
Transpl Infect Dis; 2009 Oct; 11(5):405-12. PubMed ID: 19638006
[TBL] [Abstract][Full Text] [Related]
15. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
[No Abstract] [Full Text] [Related]
16. Treatment of multidrug-resistant pseudomonas aeruginosa using extended-infusion antimicrobial regimens.
Heil EL; Lowery AV; Thom KA; Nicolau DP
Pharmacotherapy; 2015 Jan; 35(1):54-8. PubMed ID: 25556715
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
18. Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum.
Traugott KA; Echevarria K; Maxwell P; Green K; Lewis JS
Pharmacotherapy; 2011 Jun; 31(6):598-608. PubMed ID: 21923444
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa bloodstream infections: how should we treat them?
van Delden C
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S71-5. PubMed ID: 17698326
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
